Fermenta Biotech Approves Closure of Wholly-Owned UK Subsidiary
Fermenta Biotech Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 6:37 pm
Fermenta Biotech Approves Closure of Wholly-Owned UK Subsidiary Fermenta Biotech Limited's Board approved the closure of its non-material, wholly-owned subsidiary, Fermenta Biotech (UK) Limited (FBL UK), to optimize corporate structure and lower compliance costs. Acquired on 10th Sep'02, FBL UK has had no operations for several years following Brexit and the presence of an active German subsidiary, Fermenta Biotech GmbH, catering to Europe. For FY'25-26, FBL UK reported nil revenue, a net loss of 拢1,260, and net assets of 拢30,231, predominantly held as cash at bank.
Original exchange filing (PDF)
More announcements from Fermenta Biotech Ltd
- Intimation regarding earnings presentation- Q2/H1FY27. 路 06 Nov 2026
- Intimation of Press release regarding unaudited financial results of H1FY27. 路 05 Nov 2026
- Outcome of Board Meeting and Unaudited Financial Results (standalone and consolidated) for quarter ended September 30, 2026. 路 05 Nov 2026
- Unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026. 路 05 Nov 2026
- Fermenta Biotech Limited has submitted to the Exchange, the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
- FERMENTA BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the unaudited financial results (standalone and consolidated) for the period ended September 30, 2026. 路 05 Nov 2026
- Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited financial results .... 路 05 Nov 2026
